Double-ring amniotic membrane fixing ring and integrated amniotic membrane mirror

Through the amniotic fixation ring with a double-ring structure, the combination of hard resin and medical silicone materials is used to solve the problems of complexity and discomfort in traditional suture fixation, and the seamless and deformable amniotic fixation is achieved, reducing the risk of surgery and inflammatory response, and improving the risk of surgery and the response. The repair effect of corneal epithelium.

CN118948525APending Publication Date: 2024-11-15EYE HOSPITAL OF SHANDONG FIRST MEDICAL UNIVERSITY (SHANDONG EYE HOSPITAL)
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202411369243.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-29
Publication Date
2024-11-15

AI Technical Summary

Technical Problem

Traditional amniotic membrane transplantation requires suture fixation, which is complicated to operate and has a risk of infection. The existing fixation device is uncomfortable for patients with small cleft fissures or narrow conjunctival sac, and the amniotic membrane is prone to rupture and dissolution, which increases the risk of surgery and patient pain.

Method used

Design a double-ring structure amniotic membrane fixing ring, the hard inner ring is combined with the soft outer ring, the outer groove of the inner ring is designed, the soft outer ring is embedded in the hard inner ring groove, the material is hard resin and medical silicone, which is deformable , avoid suture and adapt to different eye sizes to increase wear comfort.

Benefits of technology

It achieves seamless amniotic fixation, reduces surgical pain and economic burden, reduces the risk of mechanical damage, enhances wear comfort, promotes close fit between the amniotic membrane and the cornea, reduces inflammatory response, and improves the effect of corneal epithelial repair.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118948525A_ABST
    Figure CN118948525A_ABST
Patent Text Reader

Abstract

The amniotic membrane fixing ring with the double-ring structure comprises a hard-phase inner ring and a soft-phase outer ring, a circle of groove structure is arranged on the outer side of the hard-phase inner ring, and the section of the groove structure is concave, C or tilt; shaping; and the soft-phase outer ring is a circular necklace and is embedded in the groove of the hard-phase inner ring. The amniotic membrane fixing ring can be compressed and deformed, does not need to be sutured, is convenient to operate and high in patient comfort, and reduces operation pain and economic burden. The exhaust holes are formed in the amniotic membrane, so that the amniotic membrane can be closely attached to the cornea, inflammatory reaction caused by pus accumulated below the amniotic membrane is avoided, the amniotic membrane can better play anti-inflammatory and repair-promoting roles, and complications are reduced.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention generally relates to the field of medical devices, and in particular, to a double-ring amniotic membrane fixing ring and an integrated amnioscope. Background Art

[0002] Corneal epithelial defects are common clinical problems in ophthalmology, often caused by a variety of non-infectious causes, such as mechanical trauma, chemical burns, dry eyes, neurotrophic keratitis, autoimmune diseases, etc. If corneal epithelial defects are not effectively repaired for a long time, it may cause a series of serious complications, including corneal ulcers and corneal perforations, which will not only seriously affect vision, but may even cause blindness.

[0003] The amniotic membrane is the innermost layer of the placenta. Its structure is similar to that of human conjunctival tissue and is rich in a variety of growth factors, which can provide a growth environment for corneal epithelial cells similar to that of ocular surface tissue. It also reduces immune rejection and inflammatory reactions after transplantation due to its avascular, neural and lymphatic characteristics. Therefore, the amniotic membrane has become an important means to promote the recovery of corneal epithelial damage in ophthalmology clinics.

[0004] Traditional amniotic membrane transplantation is to fix the amniotic membrane to the corneal surface by suturing under topical anesthesia or peribulbar block anesthesia. The suturing fixation method is complicated to operate, takes a long time to operate, has the risk of infection, and the risk of additional mechanical damage to the cornea, and has high requirements for the operator. The suture foreign body irritation is obvious after the operation, and if the amniotic membrane is damaged, it may rupture and dissolve prematurely, leading to a second operation, increasing the patient's pain and economic burden.

[0005] The prior art discloses some amniotic membrane fixing rings, but they only play the role of avoiding suturing, and some fixing devices are complicated to operate. Patent document No. CN213822021U discloses an amniotic membrane mirror, wherein the side wall of the conjunctival sac support device is provided with an annular groove, and a slit is provided inside to facilitate pus drainage from the ocular surface, but the disclosed support device is made of hard material and does not deform under stress, which makes it difficult for patients with small palpebral fissures or narrow conjunctival sacs to wear, and there may be a situation where the peripheral amniotic membrane and cornea are poorly attached. Summary of the invention

[0006] In order to solve the technical problems that the repair-promoting active ingredients of the amniotic membrane are damaged after treatment and that suturing is required in amniotic membrane transplantation surgery, the present invention provides an amnioscope, which is a simple fixed ring structure, utilizes the groove design on the outside of the inner ring, the double ring design of the inner and outer rings combining soft and hard, and the pressure-deformable design to fix the amniotic membrane in the conjunctival sac. It is easy to operate and comfortable to wear.

[0007] In a first aspect of the present invention, there is provided an amniotic membrane fixation ring with a double-ring structure, comprising a hard inner ring and a soft outer ring;

[0008] The outer side of the hard phase inner ring has a circle of groove structure, and the cross section is "concave", "C" or "<" shaped; the soft phase outer ring is a circular collar, embedded in the groove of the hard phase inner ring;

[0009] The performance parameters of the hard phase inner ring are: hardness 60-75 (Shore D), flexural modulus 1500-1800MPa, flexural strength 50-60MPa, tensile modulus 2000-2200MPa, tensile strength 40-50MPa, elongation at break 10-15%, notched impact strength 25-70J / m;

[0010] The performance parameters of the soft phase outer ring are: tensile strength 5-20Mpa, elongation at break 200-800%, elastic modulus 1-10MPa, hardness 20-80 (Shore A).

[0011] Preferably, the hard phase inner ring has an inner side surface, an upper surface, a lower surface and a concave card surface; the inner side surface is opposite to the concave card surface; the upper surface is symmetrical with the lower surface and partially perpendicular to the inner side surface; one end of the upper surface and the lower surface is connected to the edge of the inner side surface, and the other end extends toward the concave card surface to form a certain arc and then connect to the edge of the concave card surface. Preferably, the arc is 0.78-1.57.

[0012] Preferably, the inner diameter of the hard phase inner ring 1 is 18-28 mm, the width is 1-2.4 mm, and the height is 2-3 mm.

[0013] Preferably, the groove height is 0.3-0.8 mm; the groove depth is 0.3-0.8 mm, and the ratio of the groove depth to the hard phase inner ring width is 1:1.5-3.

[0014] Preferably, the inner diameter of the soft phase outer ring is 10-20 mm, and the cross-sectional diameter is 0.5-1.5 mm.

[0015] Preferably, the hard phase inner ring is a hard resin material, including polyvinyl chloride (PVC), polypropylene (PP), polystyrene (PS), polycarbonate (PC), epoxy resin (EP) or phenolic resin (PF).

[0016] Preferably, the soft phase outer ring is made of medical silicone, rubber, or acrylic acid-ethylene copolymer.

[0017] In a second aspect of the present invention, a suture-free amnionoscope is provided, comprising an amnion and the amnion fixing ring of the first aspect.

[0018] Preferably, vent holes are made on the edge of the amniotic membrane, the number of the vent holes is 1-8, and the diameter of the vent holes is 0.1-1 mm.

[0019] Preferably, the amniotic membrane is loaded with proanthocyanidins and methylcobalamin, wherein the loading concentration of methylcobalamin is 1.5-2.3 ug / mL, and the loading concentration of proanthocyanidins is 3-4 ug / mL.

[0020] More preferably, the loading concentration of methylcobalamin on the amniotic membrane is 2.3 ug / mL; the loading concentration of proanthocyanidins is 3.6 ug / mL.

[0021] In the third aspect of the present invention, provided is the use of the amniotic membrane mirror in the second aspect of the present invention and the amniotic membrane fixation ring in the first aspect of the present invention in the preparation of a medical device for treating or alleviating corneal epithelial defects and promoting corneal epithelial cell repair.

[0022] Beneficial effects:

[0023] 1) The amniotic membrane fixation ring of the present invention can be compressed and deformed, does not require suturing, is easy to operate, provides high patient comfort, and reduces surgical pain and economic burden.

[0024] 2) The edge of the amniotic membrane fixing ring of the present invention adopts a rounded corner design, which avoids mechanical damage such as friction or scratches on the conjunctival sac caused by right angles, reduces the foreign body sensation, and is more comfortable to wear.

[0025] 3) The fixing ring of the present invention is located at the upper and lower domes, which can reduce the occurrence of serious complications such as symblepharon and pseudopterygium to a certain extent for patients with ocular surface burns.

[0026] 4) The amnioscope of the present invention has an exhaust hole on the amniotic membrane, which can make the amniotic membrane and cornea fit closely, avoid the inflammatory reaction caused by the accumulation of pus under the amniotic membrane, and enable the amniotic membrane to better play the role of anti-inflammatory and repair promotion, thereby reducing complications. BRIEF DESCRIPTION OF THE DRAWINGS

[0027] The above and other features, advantages and aspects of the embodiments of the present invention will become more apparent with reference to the following detailed description in conjunction with the accompanying drawings. In the accompanying drawings, the same or similar reference numerals represent the same or similar elements.

[0028] Figure 1 : Schematic diagram of the three-dimensional structure of the hard phase inner ring.

[0029] Figure 2 : Side view of the hard phase inner ring.

[0030] Figure 3 : Schematic diagram of the cross section of the hard phase inner ring.

[0031] Figure 4 : Schematic diagram of the three-dimensional structure of the soft phase outer ring.

[0032] Figure 5 : Top view of the amnioscopic microscope.

[0033] Figure 6 : Schematic diagram of the cross section of the amnioscopic microscope.

[0034] Figure 7 : Physical photo of the amnioscopic instrument.

[0035] Figure 8 : General image of a rabbit eye after wearing an amnioscopic lens.

[0036] Fig. 9 : Sodium fluorescein staining of rabbit cornea.

[0037] Fig.10 :Healing rate of corneal epithelium in rabbits.

[0038] Fig.11 : Confocal microscopy imaging of neural repair in rabbit corneal epithelial defects.

[0039] Reference numerals:

[0040] 1-hard inner ring; 2-soft outer ring; 3-amniotic membrane; 4-vent;

[0041] 11 - inner side surface; 12 - upper surface; 13 - concave card surface; 1101 - edge of inner side surface 11; 1301 - edge of concave card surface 13. DETAILED DESCRIPTION

[0042] The present invention provides a simple double-ring fixing ring for fixing the amniotic membrane, achieving the effect of closely adhering to the ocular surface and not being easy to fall off.

[0043] The fixed ring is a double-ring device with a combination of soft and hard. The hard inner ring is made of hard resin material and has a circle of groove structure on the outside. The cross section of the hard inner ring is "concave", "C" or "<" shape.

[0044] The hard inner ring has moderate hardness and can maintain a nearly perfect circular shape in the conjunctival sac. It will not be deformed due to blinking and squeezing, and has good fixing and supporting effects. It can be adjusted according to the size of the conjunctival sac and the width of the palpebral fissure when worn on the eyes, while avoiding the friction of the ring on the conjunctival tissue that may cause foreign body discomfort or secondary mechanical damage.

[0045] The soft outer ring is made of medical silicone, rubber, and acrylic ethylene copolymer, and has good elasticity. It will not break even if stretched more than 2 times. After stretching, it is put on the outer periphery of the hard inner ring, fits with the groove on the outside of the hard inner ring, and is embedded in the groove. After the double rings are combined, the soft outer ring can flexibly adapt with the deformation and pressure changes of the hard inner ring, and always stably fix the amniotic membrane in the groove without dislocation.

[0046] Furthermore, the material of the soft phase outer ring is preferably medical grade silicone, because it has good biocompatibility, can reduce stimulation to the conjunctiva, avoid mechanical damage, and has a high degree of comfort.

[0047] The amniotic membrane is fixed in a fixing ring to form an integrated wearable amnioscopic mirror.

[0048] Furthermore, a plurality of drainage and exhaust holes can be provided on the inner side of the amniotic membrane close to the inner ring for draining secretions and exhausting air, so that the amniotic membrane and the cornea can be closely fitted.

[0049] The amnioscopic instrument can be stored dry and only needs to be rehydrated for 1 minute before use.

[0050] The present invention is described in detail with reference to schematic diagrams. When describing the embodiments of the present invention, for the sake of convenience, the cross-sectional diagrams showing the device structure will not be partially enlarged according to the general scale, and the schematic diagrams are only examples, which should not limit the scope of protection of the present invention. In addition, in actual production, the three-dimensional dimensions of length, width and depth should be included.

[0051] At the same time, in the description of the present invention, it should be noted that the terms "hard phase" and "soft phase" indicate the numerical comparison of the hardness of one element relative to another element. In the present invention, the inner ring has a higher hardness than the outer ring, and is called the hard phase inner ring; the outer ring has a lower hardness than the inner ring, and is called the soft phase outer ring.

[0052] The orientations or positional relationships indicated by the terms such as “upper, lower, inside and outside” are based on the orientations or positional relationships shown in the drawings and are only for the convenience of describing the present invention and simplifying the description. They do not indicate or imply that the devices or elements referred to must have a specific orientation, be constructed and operate in a specific orientation. Therefore, they should not be understood as limitations on the present invention.

[0053] Figure 1 The three-dimensional structure of the hard inner ring 1 of the amniotic membrane fixation ring is shown. Figure 2 , Figure 3 The side view and cross section of the hard phase inner ring 1 are shown. The fixed ring is a double ring structure of a soft and hard combination, including a hard phase inner ring 1 and a soft phase outer ring 2.

[0054] The outer side of the hard phase inner ring 1 has a circle of groove structure, and the cross section is "concave".

[0055] The hard phase inner ring 1 has an inner side surface 11, an upper surface 12, a lower surface (not shown) and a concave card surface 13; the inner side surface 11 is opposite to the concave card surface 13; the upper surface 12 is symmetrical with the lower surface and partially perpendicular to the inner side surface 11; one end of the upper surface 12 and the lower surface is connected to the edge 1101 of the inner side surface 11, and the other end extends toward the concave card surface 13, forming a certain arc and then connected to the edge 1301 of the concave card surface 13.

[0056] Preferably, the arc is 0.78-1.57.

[0057] The concave card surface 13 is a concave surface formed by being recessed from the edge 1301 toward the inner side surface 11 ; the recess does not penetrate the ring body and is used to embed the soft phase outer ring 2 .

[0058] In some embodiments, the inner diameter of the hard phase inner ring 1 is 18-28 mm; the width, i.e., the vertical distance from the edge 1301 of the concave card surface 13 to the inner side surface 11 is 1-2.4 mm; the height, i.e., the width of the inner side surface 11 is 2-3 mm. Preferably, different sizes are selected according to the size of the eye axis and the width of the eye fissure of different individuals, so that the hard phase inner ring is placed on the equator of the eyeball when worn.

[0059] In some embodiments, the groove height, that is, the distance between the two edges of the concave card surface 13 is 0.3-0.8 mm; the groove depth, that is, the vertical distance between the edge of the concave card surface 13 and the bottom of the depression is 0.3-0.8 mm, and the ratio of the groove depth to the hard phase inner ring width is 1:1.5~3.

[0060] In this embodiment, the inner diameter of the hard phase inner ring 1 is 20-24 mm, the width is 1-1.5 mm, and the height is 1.7-2 mm. For example, the inner diameter of the hard phase inner ring 1 is 24 mm, the width is 1.5 mm, and the height is 1.7 mm.

[0061] In this embodiment, the groove is 0.4-0.6 mm high and 0.4-0.6 mm deep. For example, the groove is 0.6 mm high and 0.6 mm deep.

[0062] The hard phase inner ring 1 is a hard resin material. In some embodiments, the material of the hard phase inner ring 1 is polyvinyl chloride (PVC), polypropylene (PP), polystyrene (PS), polycarbonate (PC), epoxy resin (EP) or phenolic resin (PF).

[0063] The hard phase inner ring 1 can be prepared by a variety of methods. In this embodiment, it is prepared by 3D printing technology. The material of the hard phase inner ring 1 is a three-dimensional light modeling resin (purchased from Dongguan Leishi 3D Printing Technology Co., Ltd., material name JS-UV-HP-2 white hard material, physical properties include density: 1.11-1.14g / cm 3 @25℃; Viscosity: 360-420cps@25℃; Curing depth: 0.135-0.155mm; Critical exposure: 9-12mJ / cm 2 ; Construction layer thickness: 0.05-0.12mm).

[0064] In this embodiment, the performance of the hard phase inner ring 1 after cleaning, sterilization and other treatments is shown in the following table:

[0065]

[0066]

[0067] The mechanical property parameters of the hard phase inner ring are measured according to the method published by the American Society for Testing and Materials (ASTM).

[0068] Figure 4 The three-dimensional structure of the soft phase outer ring 2 is shown.

[0069] In some embodiments, the soft phase outer ring 2 is an elastic circular collar with a solid circle cross section, an inner diameter of 10-20 mm, and a cross-sectional diameter of 0.5-1.5 mm. The elasticity of the soft phase outer ring 2 meets the requirement that it will not break when stretched more than 2 times. When in use, it is stretched over the outer circumference of the hard phase inner ring 1, tightly fits with the groove on the outside of the hard phase inner ring 1, and is embedded in the groove; and it can flexibly adapt to the deformation and pressure changes of the hard phase inner ring 1, and always stably fix the amniotic membrane in the groove without dislocation.

[0070] In some embodiments, the material of the soft phase outer ring 2 is medical silicone, rubber, or acrylic ethylene copolymer; the tensile strength is 5-20 MPa, the elongation at break is 200-800%, the elastic modulus is 1-10 MPa, and the hardness (Shore A) is 20-80.

[0071] In this embodiment, the soft phase outer ring 2 is a medical grade silicone O-ring, with a solid circle cross section, an inner diameter of 15 mm, a cross-sectional diameter of 0.5 mm, a tensile strength of 8-15 MPa, a breaking elongation of 400-600%, an elastic modulus of 3-8 MPa, and a hardness (Shore A) of 30-50.

[0072] The amniotic membrane fixing ring prepared by the present invention can be adjusted according to the size of the conjunctival sac and the width of the palpebral fissure before being inserted into the eye when worn; the hard inner ring preferably maintains a shape close to a perfect circle in the conjunctival sac so that it will not be deformed due to blinking and squeezing, thereby playing a fixing and supporting role; the appropriate elasticity can prevent the friction of the ring on the conjunctival tissue due to excessive hardness, causing foreign body discomfort or secondary mechanical damage.

[0073] The amniotic membrane fixing ring and the amniotic membrane are assembled to form a wearable amniotic mirror. The specific assembly method is: the amniotic membrane 3 is laid flat on the hard inner ring 1, the soft outer ring 2 is stretched to embed the periphery of the amniotic membrane 3 into the groove outside the hard inner ring 1 from above, and the excess amniotic membrane is cut off.

[0074] In some optional embodiments, the amniotic membrane 3 is laid flat in a direction with the epithelial surface (the surface with amniotic epithelial cells) facing upward or downward.

[0075] In some optional embodiments, exhaust holes 4 are made at 3, 6, 9, and 12 o'clock of the amniotic membrane 3 close to the inner side of the hard phase inner ring 1. The number of the exhaust holes is 1-8, and the diameter of the exhaust holes is 0.1-1 mm.

[0076] In this embodiment, the amniotic membrane is laid flat with the epithelial surface facing downward, the number of the vent holes 4 is 4, and the diameter of the vent holes is 0.3-0.5 mm. Figure 7 This is a physical photo of the amnioscopic device.

[0077] The amnioscopic device is stored in the following way: Place the amnioscopic device on a spherical mold in a dryer, air dry, and store at -4°C.

[0078] In some optional embodiments, the temperature in the dryer is 20-37° C. and the humidity is 20-60%. The moisture absorbing device can be moisture-proof silica gel, calcium chloride, activated carbon, aluminum oxide desiccant, regenerated moisture absorbing card, foam moisture absorbing cotton, etc.

[0079] In this embodiment, the temperature in the dryer is 21°C-25°C, and the humidity is 45%-55%. The moisture absorption device is a regenerative moisture absorption card. When in use, the amniocentoscope is placed in 1:1000 tobramycin for rehydration for 1 minute before use.

[0080] How to wear an amnionoscope: The amnionoscope has a front and back side. The side where the amnion directly covers the hard phase inner ring 1 is the front side, which faces the cornea when worn. After wearing, the amnion epithelial surface faces upward, and the amnion and cornea are tightly attached, preferably without generating bubbles.

[0081] In this embodiment, during operation, a drop of proparacaine hydrochloride eye drops is placed in the conjunctival sac, the lower eyelid is opened, the front of the amnionoscope is facing the cornea, the lower edge is placed in the lower fornix, and then the upper eyelid is lifted, the upper edge of the inner ring is gently pressed to slightly flatten, and the amnionoscope is placed in the upper fornix. After placement, close the eyes, massage the eyelids gently, adjust the position of the amnionoscope, make the amnionoscope position centered, and completely adhere to the cornea, no bubbles remain under the amnion, the eyelids can be closed and blinked normally, and the amnionoscope does not fall off. If bubbles remain under the amnion after wearing, the bubbles can be discharged from the vent by gently massaging the eyelids from top to bottom after closing the eyes. In addition, secretions or exudates under the amnion can also be discharged from the vent. Figure 8 This is the general image of a rabbit eye after wearing an amnioscopic lens.

[0082] The present invention has no limitation on the amniotic membrane used, and those skilled in the art can select the amniotic membrane obtained by different treatment methods according to actual needs and fix it in the fixing ring. In this embodiment, the amniotic membrane used is an amniotic membrane loaded with proanthocyanidins and methylcobalamin, and the preparation steps are as follows:

[0083] S0. Pretreatment: Take fresh amniotic membrane, rinse with sterile saline, and place in antibiotic saline (2.5ug / mL amphotericin B, 1:1000 tobramycin, 1:2000 penicillin) for 20-60 minutes, for example, 40 minutes. Scrape off the sponge layer, part of the fibroblast layer and serous exudate under a microscope. Attach a sterile nitrocellulose membrane (NC membrane) to it, with the amniotic epithelium facing up, and trim it to a suitable size according to actual needs. In this embodiment, the amniotic membrane (sheet) is trimmed into a size of 3cm×3cm.

[0084] S1. Prepare a mixed solution: in the mixed solution, the concentration of proanthocyanidins is 3-10 mg / mL; the concentration of methylcobalamin is 0.1-0.8 mg / mL; the concentration of NHS is 8-20 mg / mL. In this example, 25 mg of proanthocyanidins, 2.5 mg of methylcobalamin, and 50 mg of NHS are dissolved in 5 mL of PBS buffer.

[0085] In some embodiments, the pH of the mixed solution is adjusted to 6.5-7.5, because the pH value of tears is usually between 6.5 and 7.5, and in this range, it can be similar to tears and reduce irritation to the eyes. In this embodiment, 0.3% boric acid is added to adjust the pH value to between 6.5-7.5.

[0086] In this embodiment, the dissolution method is to subject the mixed solution to ultrasonic treatment in a 37° C. water bath for 20 min at an energy of 20 Hz to completely dissolve it and form a uniform solution.

[0087] S2. Cross-linking the amniotic membrane: Place the amniotic membrane into the mixed solution prepared in step S1, ensuring that the entire surface is covered, and let it react at room temperature (15-25°C) for 30 minutes to 3 hours, for example, 45 minutes, 1 hour, 1.5 hours, or 2 hours.

[0088] S3. Washing: Remove the amniotic membrane and wash it in PBS for 5 times, 20 minutes each time, to remove unreacted reagents and by-products.

[0089] In some embodiments, ultra-high performance liquid chromatography is used to measure the loading rates of proanthocyanidins and methylcobalamin, and the loading concentration of methylcobalamin is measured to be 1.5-2.3 ug / mL, and the loading concentration of proanthocyanidins is 3-4 ug / mL.

[0090] In this embodiment, the average loading concentration of methylcobalamin is 2.3 ug / mL; the average loading concentration of proanthocyanidins is 3.6 ug / mL.

[0091] Animal experiments

[0092] After anesthetizing 12 New Zealand white rabbits, the corneal epithelium and basement membrane within 11mm of the rabbit cornea were scraped with an epithelial knife. Six of the rabbits were randomly selected to wear the fixing ring (amniotic lens group) prepared by the present invention, which was fixed with amniotic membrane loaded with proanthocyanidins and methylcobalamin (the loading concentration of methylcobalamin was 2.3ug / mL; the loading concentration of proanthocyanidins was 3.6ug / mL), and the remaining 6 rabbits were not treated (control group). Three and five days after the operation, corneal slit lamp photography and sodium fluorescein staining were used to record the healing of the corneal epithelium, redness of the eyes, secretions and other abnormalities. The results are as follows Fig. 9 As shown in the figure, the conjunctiva of the control group was obviously congested after the corneal epithelium was scraped off, and inflammation persisted. Seven days after surgery, the corneal epithelium was still not healed within a range of nearly 3mm by corneal fluorescein sodium staining. In the amniotic membrane group, conjunctival congestion was not obvious, the inflammatory reaction was mild, the corneal epithelium was nearly healed 5 days after surgery, and the corneal epithelium was completely healed 7 days after surgery, indicating that wearing an amniotic membrane lens can reduce the inflammatory reaction of the ocular surface and promote the healing of the corneal epithelium.

[0093] One month after surgery, Image J software was used to calculate the healing rates of corneal epithelium in the two groups. Fig.10 As shown in the results, the healing speed of corneal epithelium in the amniotic microscope group was significantly faster than that in the blank control group, and the difference was statistically significant. There was one case of corneal ulcer in the control group, and no infection occurred during the epithelial healing period in the amniotic microscope group. No obvious purulent secretions were found in the amniotic microscope group. After one week of observation, the amniotic membrane dissolution rate was 0% and the lens removal rate was 0%. No obvious mechanical damage was found in the conjunctival sac, and no bleeding, exudation, or granulation hyperplasia occurred, indicating that the amniotic microscope can effectively promote corneal epithelial healing and has anti-inflammatory, antibacterial, and repair-promoting functions. In addition, after wearing the amniotic microscope for a long time, no damage to the rabbit's eye tissue caused by wearing the amniotic microscope was found, and no uncomfortable behavior of the rabbit was found due to wearing the amniotic microscope.

[0094] One month after surgery, the rabbits were killed, their eyeballs were removed, and corneal tissue was obtained and observed using a confocal laser microscope. Fig.11 As shown, the corneal nerve fibers in the control group did not regenerate, but the nerve fibers in the amniotic membrane group regenerated, indicating that the amniotic membrane loaded with proanthocyanidins and methylcobalamin can promote the regeneration of corneal nerves.

[0095] The above specific implementations do not constitute a limitation on the protection scope of the present invention. It should be understood by those skilled in the art that various modifications, combinations, sub-combinations and substitutions can be made according to design requirements and other factors. Any modification, equivalent substitution and improvement made within the spirit and principle of the present invention should be included in the protection scope of the present invention.

Claims

1. An amniotic membrane fixation ring with a double ring structure, comprising a hard inner ring and a soft outer ring; The hard phase inner ring has a circle of grooves on the outside, and the cross section is "concave", "C" or "<" shaped; the soft phase outer ring is a circular collar, embedded in the groove of the hard phase inner ring; The performance parameters of the hard phase inner ring are: hardness 60-75 (Shore D), flexural modulus 1500-1800MPa, flexural strength 50-60MPa, tensile modulus 2000-2200MPa, tensile strength 40-50MPa, elongation at break 10-15%, notched impact strength 25-70J / m; The performance parameters of the soft phase outer ring are: tensile strength 5-20Mpa, elongation at break 200-800%, elastic modulus 1-10MPa, hardness 20-80 (Shore A).

2. The amniotic membrane fixation ring according to claim 1, characterized in that: The inner diameter of the hard phase inner ring is 18-28mm; the width is 1-2.4mm; the height is 2-3mm; The groove height is 0.3-0.8 mm; the groove depth is 0.3-0.8 mm, and the ratio of the groove depth to the hard phase inner ring width is 1:1.5-3.

3. The amniotic membrane fixation ring according to claim 1, characterized in that: The inner diameter of the soft phase outer ring is 10-20 mm, and the cross-sectional diameter is 0.5-1.5 mm.

4. The amniotic membrane fixation ring according to claim 1, characterized in that: The hard phase inner ring has an inner side surface, an upper surface, a lower surface and a concave card surface; the inner side surface is opposite to the concave card surface; the upper surface is symmetrical with the lower surface and partially perpendicular to the inner side surface; one end of the upper surface and the lower surface is connected to the edge of the inner side surface, and the other end extends toward the concave card surface to form an arc of 0.78-1.57 and then connected to the edge of the concave card surface.

5. The amniotic membrane fixation ring according to claim 1, characterized in that: The hard phase inner ring is made of hard resin material, including polyvinyl chloride, polypropylene, polystyrene, polycarbonate, epoxy resin or phenolic resin; The soft phase outer ring is made of medical silicone, rubber or acrylic acid ethylene copolymer.

6. A suture-free amnionoscope, characterized in that: The invention comprises an amniotic membrane and an amniotic membrane fixation ring as described in any one of claims 1-5.

7. The amnioscopic device according to claim 6, wherein: The amniotic membrane is provided with vent holes, the number of the vent holes is 1-8, and the diameter of the vent holes is 0.1-1 mm.

8. The amnioscopic device according to claim 6 or 7, characterized in that: The amniotic membrane is loaded with proanthocyanidins and methylcobalamin; the loading concentration of methylcobalamin is 1.5-2.3ug / mL, and the loading concentration of proanthocyanidins is 3-4ug / mL.

9. The amnionoscope according to claim 8, characterized in that: The loading concentration of methylcobalamin was 2.3ug / mL; the loading concentration of proanthocyanidins was 3.6ug / mL.

10. Use of the amniotic membrane fixation ring as described in any one of claims 1 to 5, or the amniotic membrane mirror as described in any one of claims 6 to 9, in the preparation of a medical device for treating or alleviating corneal epithelial defects and promoting corneal epithelial cell repair.

Citation Information

Cited By

  • Amniotic membrane mirror with low foreign body sensation and preparation method of amniotic membrane mirror

    CN119837698A